Pharma leaders must take a “construction crew” mindset and start treating workforce development in the same manner as they do ...
If trust, transparency, and accountability remain core values in medicine, AI governance cannot be left to improvisation.
Scholar Rock’s Isembyld isn’t the only FDA-approved therapy for spinal muscular atrophy, but it is the first one that ...
Nara Health’s funding was led by Khosla Ventures, with participation from Long Journey Ventures and Superior Studios.
Inspiren, a company selling an AI-powered senior living platform, raised $70 million in Series C funding led by NewView ...
Forus' $150 million Series C round was led by Bain Capital Ventures, with participation from Thrive Capital, General Catalyst ...
Rep. Frank Pallone, Jr., is seeking information from six IDR entities amid concerns about No Surprises Act arbitration ...
In a mid-stage study, Teva’s drug prevented intestinal damage in celiac disease patients who underwent a gluten challenge — ...
GSK’s messenger RNA vaccine for seasonal influenza is designed to prompt an immune response to two proteins on the surface of ...
Interra Health, a health tech platform for prescribing, announced Thursday that it is now supporting the Medicare GLP-1 ...
Flare Capital Partners led the Series A round. Craft, Obvious Ventures, Eniac Ventures, InHealth Ventures, Epsilon Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results